HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic

American Journal of Public Health

Volumn 90, Issue 3, 2000, Pages 352-359

  Des Jarlais, Don C ^a   Marmor, Michael ^b   Friedmann, Patricia ^a   Titus, Stephen ^b   Aviles, Eliza ^a   Deren, Sherry ^c   Torian, Lucia ^d   Glebatis, Donna ^e   Murrill, Christopher ^f   Monterroso, Edgar ^f   Friedman, Samuel R ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; EPIDEMIC; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; SEROCONVERSION; UNITED STATES;

EID: 0034010750     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.90.3.352     Document Type: Article

References (33)

1. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642-654.
2. Coates TJ, Aggleton P, Gutzwiller F, et al. HIV prevention in developed countries. Lancet. 1996;348:1143-1148.
3. Mann JM, Tarantola DJM, eds. AIDS in the World II: Global Dimensions, Social Roots, and Responses. New York, NY: Oxford University Press: 1996.
4. Friedman S, Jose B. Deren S, Des Jarlais D, Neaigus A, Consortium NA. Risk factors for HIV seroconversion among out-of-treatment drug injectors in high- and low-seroprevalence cities. Am J Epidemiol. 1995;142:864-874.
5. Anderson R. Trends in HIV incidence and prevalence: natural course of the epidemic or results of behavior change? Paper presented at: UNAIDS Meeting on HIV Prevalence Studies; October 1997; Oxford, England.
6. New York City Department of Health. AIDS Surveillance Update. New York, NY: New York City Department of Health; 1998.
7. WHO-EC Collaborating Centre on AIDS. Second Quarterly Report 1998. Paris, France: European Centre for the Epidemiological Monitoring of AIDS; 1998.
8. Des Jarlais DC, Friedman SR, Novick D, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261:1008-1012.
9. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA. 1994;271:121-127.
10. Des Jarlais DC, Friedman SR, Perlis T, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:67-72.
11. Marmor M, Titus S, Wolfe H, et al. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. AIDS Res Hum Retroviruses. 1994;10(suppl 2):S207-S213.
12. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987-991.
13. Johnson AM, Parry JV, Best SJ, Smith AM, de Silva M, Mortimer PP. HIV surveillance by testing saliva. AIDS. 1988;2:369-371.
14. Rosner B. Fundamentals of Biostatistics. New York, NY: Duxbury Press; 1995.
15. Cooper H, Hedges L, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994.
16. Fleiss J, ed. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
17. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 1998;113(suppl 1): 107-115.
18. Des Jarlais DC, Friedman SR, Marmor M, et al. Development of AIDS, HIV seroconversion, and potential co-factors forT4 cell loss in a cohort of intravenous drug users. AIDS. 1987;1:105-111.
19. MEDLINE [database online]. Bethesda, Md: National Institutes of Health, US National Library of Medicine; 1976.
20. AIDSLINE [database online]. Bethesda, Md: National Institutes of Health, US National Library of Medicine; 1988.
21. Broers B, Junet C, Bourquin M, Deglon JJ, Perris L, Hirschel B. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS. 1998; 12:2059-2066.
22. Battegay M, Naef MR, Bucher HC, Diamantis L. Bassetti S, Gyr N. Low seroconversion rate of HIV and of hepatitis A virus infection during an intravenous opiate maintenance trial. Paper presented at: 12th International Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland.
23. Kitayaporn D, Vanichseni S, Mastro T, et al. HIV-1 incidence, subtypes, and follow up in a prospective cohort of injecting drug users (IDUs) in Bangkok, Thailand. Paper presented at: 12th International Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland.
24. van Ameijden E, Coutinho R. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12:625-634.
25. Nelson KE, Vlahov D, Solomon L, Cohn S, Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med. 1995;155:1305-1311.
26. Des Jarlais DC, Perils T, Friedman SR, et al. Risk reduction in a declining HIV epidemic: injecting drug users in New York City, 1990-1997. In press.
27. Wawer MJ, Serwadda D, Gray RH, et al. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS, 1997;11:1023-1030.
28. Kilian AHD, Gregson S, Ndyanabangi B, et al. Reductions in risk behaviour provide the most consistent explanation for declining HIV-1 prevalence in Uganda. AIDS. 1999;13: 391-398.
29. Nelson K, Celentano D, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med. 1996;335:297-303.
30. Nelson K, Eiumtrakol S, Celantano D, Beyrer C, Kuntobutria S, Khamoonruang C. HIV infection among young men in Northern Thailand, 1991-1997. Paper presented at: 12th International Conference on AIDS; June 28-July 3, 1998; Geneva, Switzerland.
31. New York City Department of Health. Report of the Expert Panel on HIV Seroprevalence Estimates and AIDS Case Projection Methodologie. New York, NY: New York City Department of Health; 1989.
32. Eisenhandler J, Drucker E. Opiate dependency among the subscribers of a New York area private insurance plan. JAMA. 1993; 269:2890-2891.
33. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Am Key Respir Dis. 1991; 144:745-749.